SUAH PARK: Open Payments
NPI 1316563091 · LAKEWOOD, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,345 in 71 payments from 16 companies in 2025. Trend: 2023 $818 · 2024 $948 · 2025 $1,345
Food & beverage: $1,277Long term medical supply or device loan: $50Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $355 |
| Orexo US, Inc. | 16 | $231 |
| AstraZeneca Pharmaceuticals LP | 8 | $196 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $74 |
| Abbott Laboratories | 2 | $68 |
| Phathom Pharmaceuticals, Inc. | 3 | $63 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Viatris Specialty LLC | 3 | $53 |
| Aimmune Therapeutics, Inc. | 2 | $45 |
| Alexion Pharmaceuticals, Inc. | 2 | $43 |
Products named: LINZESS, Zubsolv, AIRSUPRA, JARDIANCE, QULIPTA, VOQUEZNA, YUPELRI, FREESTYLE INSULINX.
Industry payments across WA — which companies pay providers there.
